Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1997-6-19
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0306-5456
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
644
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9166218-Abortifacient Agents, Nonsteroidal,
pubmed-meshheading:9166218-Abortion, Induced,
pubmed-meshheading:9166218-Administration, Intravaginal,
pubmed-meshheading:9166218-Administration, Oral,
pubmed-meshheading:9166218-Female,
pubmed-meshheading:9166218-Humans,
pubmed-meshheading:9166218-Misoprostol,
pubmed-meshheading:9166218-Pregnancy
|
pubmed:year |
1997
|
pubmed:articleTitle |
Oral versus vaginal misoprostol for cervical priming.
|
pubmed:publicationType |
Letter,
Comment
|